Abstract

BackgroundAssociating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can induce a stronger regenerative ability than traditional 2-stage hepatectomy (TSH). ALPPS has become popular for achieving fast hypertrophy in patients with an insufficient future liver remnant (FLR). However, ALPPS is associated with high morbidity and mortality. Partial ALPPS is a variation that may decrease the morbidity and mortality. The purpose of this study was to perform a meta-analysis comparing outcomes of ALLPS and partial ALLPS.MethodsPubMed, Embase, and Cochrane Library databases were searched for studies comparing partial ALPPS and complete ALPPS up to April 2019. Included studies were assessed by the Newcastle-Ottawa Scale (NOS). Weighted mean difference (WMD)/standard mean difference (SMD) and odds ratios (OR) with 95% confidence intervals (CIs) were calculated to compare FLR, time interval between stages, postoperative complications, and mortality between partial and complete ALPPS.ResultsFour studies including 124 patients were included. FLR hypertrophy of partial ALPPS was comparable to complete ALPPS (p = 0.09). The time interval between stages was not different between the 2 procedures (p = 0.57). The postoperative complications rate of partial ALPPS was significantly lower than that of complete ALPPS (OR = 0.38; p = 0.03). The mortality rate of partial ALLPS (4.9%) was lower than that of complete ALLPS (18.9%), but the difference was not significant (OR = 0.37; p = 0.12).ConclusionsPartial ALLPS is associated with similar FLR hypertrophy and time interval between stages as complete ALLPS, and a lower complication rate. Further studies are needed to examine patient selection and outcomes of the 2 procedures.

Highlights

  • Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can induce a stronger regenerative ability than traditional 2-stage hepatectomy (TSH)

  • An extensive hepatectomy cannot be performed if there will be an insufficient future liver remnant (FLR) because it may lead to posthepatectomy liver failure (PHLF)

  • In traditional 2-stage hepatectomy, liver hypertrophy can be induced after stage 1 by portal vein embolization (PVE) or portal vein ligation (PVL), and the FLR can meet the size requirement for the second stage

Read more

Summary

Introduction

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can induce a stronger regenerative ability than traditional 2-stage hepatectomy (TSH). ALPPS has become popular for achieving fast hypertrophy in patients with an insufficient future liver remnant (FLR). An extensive hepatectomy cannot be performed if there will be an insufficient future liver remnant (FLR) because it may lead to posthepatectomy liver failure (PHLF). In 2007, Schlitt et al performed the first “in-situ split” procedure [5], which was named “Associating Liver Partition and Portal vein ligation for Staged hepatectomy” (ALPPS) by Clavien. ALPPS was performed by separating the future liver remnant and the diseased hemi-liver in the first stage with an in-situ split, in combination with PVL. A serious complication (ClavienDindo > grade 3) rate of 44% and a mortality rate of 12% has limited the application of ALPPS [5]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call